RAYSA MORALES DEMORI to Humans
This is a "connection" page, showing publications RAYSA MORALES DEMORI has written about Humans.
Connection Strength
0.155
-
Pediatric Pulmonary Hypertension. Pediatr Rev. 2024 May 01; 45(5):251-259.
Score: 0.025
-
Surgical and Cardiac Catheterization Outcomes of Scimitar Syndrome Patients: A Three Decade Single-Center Experience. Pediatr Cardiol. 2023 Mar; 44(3):579-586.
Score: 0.022
-
Outcomes of COVID-19 infection in pediatric pulmonary hypertension: A single-center experience. Pediatr Pulmonol. 2021 12; 56(12):3960-3965.
Score: 0.021
-
Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study. Pediatr Cardiol. 2021 Aug; 42(6):1297-1307.
Score: 0.020
-
Congenital heart disease and cardiac procedural outcomes in patients with trisomy 21 and Turner syndrome. Congenit Heart Dis. 2017 Dec; 12(6):820-827.
Score: 0.016
-
Trend of Endurance Level Among Healthy Inner-City Children and Adolescents Over Three Decades. Pediatr Cardiol. 2017 Jan; 38(1):123-127.
Score: 0.015
-
The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
Score: 0.011
-
Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial. Am J Ther. 2013 Nov-Dec; 20(6):622-9.
Score: 0.006
-
Under Pressure: The Pulmonary Vasculature and Its Role in the Pediatric Cardiac ICU. Am J Respir Crit Care Med. 2021 08 15; 204(4):391-392.
Score: 0.005
-
Impact of surfactant when utilized during pediatric cardiac surgery admissions: analysis of a nationwide database. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):7819-7825.
Score: 0.005
-
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
Score: 0.003
-
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
Score: 0.003
-
Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
Score: 0.003